Why IVF Fails: 8 Reasons and What to Do Next

A failed IVF cycle is one of the most emotionally difficult experiences a couple can face — and the search for an explanation begins almost immediately. Why did it not work? Was something wrong? What can be done differently?

The honest answer is that IVF failure is common. Even at excellent centres, IVF succeeds only 40 to 55% of the time in the best-case patient group. For most couples, the first cycle will not result in a baby — and this is not a reflection of the quality of the treatment or the capability of the clinic. It is the biology of human reproduction.

What separates a centre that helps couples eventually succeed from one that leaves them in a cycle of unexplained failure is the ability to systematically investigate why a cycle failed, identify modifiable factors, and adjust the approach for the next attempt. Here are the 8 most important reasons IVF cycles fail.

1. Embryo Chromosomal Abnormality

The most common cause of IVF failure — and of human reproduction failure in general — is chromosomal abnormality in the embryo. The majority of embryos produced in IVF, particularly in older women, carry an incorrect number of chromosomes (aneuploid). An aneuploid embryo either fails to implant at all, or implants and miscarries.

This is why preimplantation genetic testing (PGT-A) — biopsy and chromosomal analysis of blastocysts before transfer — is being used increasingly for selected patients. By transferring only euploid (chromosomally normal) embryos, PGT-A significantly reduces the miscarriage rate and may improve live birth rates per transfer — particularly in women over 35 and in couples with recurrent implantation failure.

2. Poor Egg Quality

Egg quality is not the same as egg quantity. A woman can have a normal antral follicle count and AMH but produce eggs that are chromosomally abnormal — particularly as she ages. The proportion of chromosomally normal eggs declines from approximately 70 to 80% at age 25 to 30% or lower by age 40 to 42.

Poor egg quality is currently difficult to improve significantly — it is primarily driven by age and cannot be measured by any current non-invasive test. Mitochondrial support supplements (CoQ10) have some evidence for modest benefit, particularly in women over 37. For women with severely compromised egg quality due to advanced age, donor egg IVF offers dramatically higher success rates.

3. Sperm DNA Fragmentation

A semen analysis can be completely normal — normal count, motility, and morphology — and yet the sperm can carry high levels of DNA damage (fragmentation). Sperm with fragmented DNA may fertilise eggs normally but produce embryos that arrest early, fail to implant, or miscarry shortly after a positive test.

Sperm DNA fragmentation testing is not routinely included in a standard semen analysis — it must be specifically requested. For couples with unexplained IVF failure or poor embryo development, it is one of the most important tests to perform before proceeding to another cycle. Treatment options include antioxidant therapy, varicocele repair if present, and consideration of IMSI or testicular sperm retrieval.

4. Implantation Failure — Endometrial Factors

A high-quality embryo requires a receptive uterine lining to implant successfully. Endometrial factors that can impair implantation include:

• Thin endometrium: A lining below 6 to 7 mm at the time of transfer has significantly lower implantation rates. Treatment options include high-dose oestrogen, aspirin, sildenafil, and — in refractory cases — intrauterine PRP.
• Uterine polyps or submucosal fibroids: Even small lesions inside the cavity can prevent implantation. Hysteroscopy before IVF is recommended to confirm a clear cavity.
• Uterine septum or adhesions: Intrauterine adhesions (Asherman's syndrome) or a septum can prevent normal embryo implantation.
• Displaced window of implantation: The endometrium is receptive only during a narrow window (typically LH+7). Some women have a displaced window — earlier or later than expected. The ERA (Endometrial Receptivity Analysis) test identifies displaced windows and allows personalised transfer timing.

5. Poor Ovarian Response to Stimulation

In a poor responder — typically someone with low AMH and low antral follicle count — ovarian stimulation produces fewer eggs than expected. With fewer eggs, the probability of at least one chromosomally normal blastocyst being available for transfer is reduced. Poor responders need highly tailored protocols, sometimes including mild stimulation approaches, priming strategies, or consideration of pooling multiple stimulation cycles before transfer.

6. Hydrosalpinx

A hydrosalpinx — a blocked fallopian tube filled with fluid — is toxic to embryos. The fluid drains retrograde into the uterine cavity and creates a hostile environment for implantation. Studies show that hydrosalpinx can reduce IVF success rates by up to 50%. If a hydrosalpinx is present, it should be managed — by salpingectomy (tube removal) or cornual occlusion — before IVF is attempted. Proceeding with IVF in the presence of an untreated hydrosalpinx significantly compromises the cycle outcome.

7. Laboratory Quality

The embryology laboratory is where fertilisation, culture, and vitrification happen — and its quality directly influences outcomes. Incubator stability, culture media selection, air quality control, vitrification protocols, and embryologist expertise are not visible to patients from the outside but drive results more than almost any other factor. A cycle can fail not because of anything inherently wrong with the patient's eggs or sperm, but because of suboptimal laboratory conditions. This is why laboratory quality should be a central criterion in choosing a clinic — not just the doctor's reputation alone.

8. Systemic Medical Factors

Several systemic conditions can impair implantation and must be identified and treated before IVF:

• Uncontrolled thyroid disease: Both hypo- and hyperthyroidism impair implantation and increase miscarriage risk. TSH should be within the fertility-specific range (ideally below 2.5 mIU/L) before transfer.
• Antiphospholipid syndrome: An autoimmune condition causing micro-clots in placental vessels, associated with implantation failure and pregnancy loss. Treatable with aspirin and low-molecular-weight heparin.
• Uncontrolled diabetes: Impairs implantation and is associated with early pregnancy loss.
• Elevated prolactin: Suppresses the luteal phase and impairs endometrial preparation.

Frequently Asked Questions

Q1. After how many failed IVF cycles should I investigate further?

After two to three failed cycles with good-quality embryos and no identified cause, a comprehensive investigation of implantation factors is warranted. This includes hysteroscopy, sperm DNA fragmentation, thrombophilia screen, thyroid antibodies, antiphospholipid antibodies, and ERA testing in selected cases. Some investigations are worth doing earlier if there is a specific clinical signal.

Q2. Does a failed IVF cycle tell us anything useful?

Yes — a great deal. Fertilisation rates, embryo development patterns, quality of blastocysts produced, and the behavior of the lining are all informative. A skilled clinic uses every cycle — including failed ones — to refine the approach for the next. A failed cycle should generate a structured review, not just an offer to repeat the same protocol.

Q3. When should I consider changing clinics after repeated failures?

If two to three cycles at a centre have not produced either a pregnancy or a systematic change in approach — protocol modification, investigation of implantation factors, review of laboratory conditions — it is reasonable to seek a second opinion. Not because the clinic is necessarily at fault, but because a fresh clinical perspective occasionally identifies something that has been missed.

Q4. Does stress cause IVF failure?

Severe chronic stress can affect the hormonal environment relevant to reproduction — elevated cortisol can impair the pituitary-ovarian axis and the luteal phase. However, the acute stress of the IVF process itself does not cause implantation failure. The evidence for any direct causal relationship between stress and IVF outcome is weak. This does not mean stress management is unimportant — it matters for quality of life and resilience through what is inherently a difficult process.